Clinical Trials and Research Studies
Phase 1/2
A PHASE l/ll OPEN LABEL MULTI-CENTER STUDY OF IMMUNE CHECKPOINT THERAPY WITH NIVOLUMAB FOR PATIENTS WITH LOCALLY ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Learn MorePhase 3
A Randomized Multicenter Double Blind Phase III Study of Adjuvant Nivolumab or Placebo in Subjects With Resected Esophageal or Gastroesophageal Junction Cancer
Learn More